• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

由于TERC基因突变导致的先天性角化不良家族中,疾病预期与端粒逐渐缩短相关。

Disease anticipation is associated with progressive telomere shortening in families with dyskeratosis congenita due to mutations in TERC.

作者信息

Vulliamy Tom, Marrone Anna, Szydlo Richard, Walne Amanda, Mason Philip J, Dokal Inderjeet

机构信息

Department of Haematology, Division of Investigative Science, Imperial College London, Hammersmith Hospital, DuCane Rd, London W12 ONN, UK.

出版信息

Nat Genet. 2004 May;36(5):447-9. doi: 10.1038/ng1346. Epub 2004 Apr 18.

DOI:10.1038/ng1346
PMID:15098033
Abstract

Telomerase is a ribonucleoprotein complex that is required to synthesize DNA repeats at the ends of each chromosome. The RNA component of this reverse transcriptase is mutated in the bone marrow failure syndrome autosomal dominant dyskeratosis congenita. Here we show that disease anticipation is observed in families with this disease and that this is associated with progressive telomere shortening.

摘要

端粒酶是一种核糖核蛋白复合体,在每条染色体末端合成DNA重复序列时不可或缺。这种逆转录酶的RNA成分在骨髓衰竭综合征常染色体显性遗传性先天性角化不良中发生突变。我们在此表明,在患有这种疾病的家族中可观察到疾病早现现象,且这与端粒的逐渐缩短有关。

相似文献

1
Disease anticipation is associated with progressive telomere shortening in families with dyskeratosis congenita due to mutations in TERC.由于TERC基因突变导致的先天性角化不良家族中,疾病预期与端粒逐渐缩短相关。
Nat Genet. 2004 May;36(5):447-9. doi: 10.1038/ng1346. Epub 2004 Apr 18.
2
Dyskeratosis congenita: telomerase, telomeres and anticipation.先天性角化不良:端粒酶、端粒与遗传早现
Curr Opin Genet Dev. 2005 Jun;15(3):249-57. doi: 10.1016/j.gde.2005.04.004.
3
Mutations in the reverse transcriptase component of telomerase (TERT) in patients with bone marrow failure.骨髓衰竭患者端粒酶逆转录酶成分(TERT)的突变。
Blood Cells Mol Dis. 2005 May-Jun;34(3):257-63. doi: 10.1016/j.bcmd.2004.12.008.
4
Telomeres in dyskeratosis congenita.先天性角化不良中的端粒。
Nat Genet. 2004 May;36(5):437-8. doi: 10.1038/ng0504-437.
5
Haploinsufficiency of telomerase reverse transcriptase leads to anticipation in autosomal dominant dyskeratosis congenita.端粒酶逆转录酶单倍剂量不足导致常染色体显性遗传性先天性角化不良的遗传早现。
Proc Natl Acad Sci U S A. 2005 Nov 1;102(44):15960-4. doi: 10.1073/pnas.0508124102. Epub 2005 Oct 24.
6
The effect of TERC haploinsufficiency on the inheritance of telomere length.TERC单倍剂量不足对端粒长度遗传的影响。
Proc Natl Acad Sci U S A. 2005 Nov 22;102(47):17119-24. doi: 10.1073/pnas.0505318102. Epub 2005 Nov 11.
7
TERC mutations in children with refractory cytopenia.难治性血细胞减少症患儿的TERC基因突变
Haematologica. 2006 May;91(5):707-8.
8
Dyskeratosis congenita: molecular insights into telomerase function, ageing and cancer.先天性角化不良:对端粒酶功能、衰老和癌症的分子见解
Expert Rev Mol Med. 2004 Dec 20;6(26):1-23. doi: 10.1017/S1462399404008671.
9
Stem cells, telomerase and dyskeratosis congenita.干细胞、端粒酶与先天性角化不良
Bioessays. 2003 Feb;25(2):126-33. doi: 10.1002/bies.10229.
10
Expanding the clinical phenotype of autosomal dominant dyskeratosis congenita caused by TERT mutations.扩展由端粒酶逆转录酶(TERT)突变引起的常染色体显性先天性角化不良的临床表型。
Haematologica. 2008 Jun;93(6):943-4. doi: 10.3324/haematol.12317. Epub 2008 May 6.

引用本文的文献

1
Telomerase activity in T-cells as a functional test for pathogenicity assessment of novel genetic variants in telomere biology disorders.T细胞中的端粒酶活性作为端粒生物学障碍中新型基因变异致病性评估的功能测试。
Sci Rep. 2025 Aug 8;15(1):29048. doi: 10.1038/s41598-025-12566-7.
2
Telomere attrition alters extracellular vesicles conferring adverse impacts on neuronal viability and inflammatory response.端粒损耗会改变细胞外囊泡,对神经元活力和炎症反应产生不利影响。
iScience. 2025 May 13;28(6):112661. doi: 10.1016/j.isci.2025.112661. eCollection 2025 Jun 20.
3
Polygenic modifiers impact penetrance and expressivity in telomere biology disorders.
多基因修饰因子影响端粒生物学障碍中的外显率和表现度。
J Clin Invest. 2025 Jun 3. doi: 10.1172/JCI191107.
4
Telomeropathies in Interstitial Lung Disease and Lung Transplant Recipients.间质性肺疾病和肺移植受者中的端粒病
J Clin Med. 2025 Feb 24;14(5):1496. doi: 10.3390/jcm14051496.
5
A novel TERT variant associated with a telomere biology disorder and challenges in variant classification.一种与端粒生物学障碍相关的新型TERT变异体及变异体分类面临的挑战。
EJHaem. 2025 Jan 24;6(1):e1066. doi: 10.1002/jha2.1066. eCollection 2025 Feb.
6
A Review of Telomere Attrition in Cancer and Aging: Current Molecular Insights and Future Therapeutic Approaches.癌症与衰老中端粒损耗的综述:当前的分子见解及未来的治疗方法
Cancers (Basel). 2025 Jan 14;17(2):257. doi: 10.3390/cancers17020257.
7
Telomere length as a biomarker for cerebrovascular diseases: current evidence.端粒长度作为脑血管疾病的生物标志物:当前证据。
Mol Biol Rep. 2024 Nov 13;51(1):1150. doi: 10.1007/s11033-024-10077-8.
8
Roles of chromatin and genome instability in cellular senescence and their relevance to ageing and related diseases.染色质和基因组不稳定性在细胞衰老中的作用及其与衰老和相关疾病的关系。
Nat Rev Mol Cell Biol. 2024 Dec;25(12):979-1000. doi: 10.1038/s41580-024-00775-3. Epub 2024 Oct 3.
9
The evolving genetic landscape of telomere biology disorder dyskeratosis congenita.端粒生物学障碍先天性角化不良的不断演变的遗传景观。
EMBO Mol Med. 2024 Oct;16(10):2560-2582. doi: 10.1038/s44321-024-00118-x. Epub 2024 Aug 28.
10
Telomere-lengthening germline variants predispose to a syndromic papillary thyroid cancer subtype.端粒延长种系变异易患综合征型甲状腺乳头状癌亚型。
Am J Hum Genet. 2024 Jun 6;111(6):1114-1124. doi: 10.1016/j.ajhg.2024.04.006. Epub 2024 Apr 29.